Feedback / Questions
Elahere (mirvetuximab soravtansine-gynx) - AbbVie
https://www.targetedonc.com/view/mirvetuximab-active-in-platinum-sensitive-ovarian-cancer-regardless-of-hrd-status
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next